Rebamipide as a Potential Alternative GPA for PPI

In this way, rebamipide counteracts some of the causes of NSAID-induced lower gastrointestinal tract injury Rebamipide has been shown to be

Rebamipide is an amino acid analog of 2 -quinolinone It is being introduced and used since 1980 for the treatment of peptic ulcer

rebamipide General improvement rate was remarkable % and effectiveness rate of Rebamipide was % after 8 weeks of treatment No significant clinical side effects

rebamipide Rebamipide is an amino acid analog of 2 -quinolinone It is being introduced and used since 1980 for the treatment of peptic ulcer